Description
Metenolone enanthate is an androgen and anabolic steroid (AAS) used to treat anemia caused by bone marrow loss. It is injected into muscle. Despite its widespread usage in the past, the medication is currently mainly exclusively accessible on the illicit market. Metenolone acetate is a similar medication.
Metenolone enanthate side effects include acne, hair growth, voice changes, and increased sexual desire. Androgen receptor (AR) agonists like testosterone and dihydrotestosterone are biological targets of the medication (DHT). It has mild anabolic and androgenic effects, minimal estrogenic effects, and no danger of liver damage. Metenolone enanthate is a long-lasting prodrug of metenolone.
It was approved for medicinal usage in 1962. Metenolone enanthate is also utilized to enhance physique and performance. In many countries, the drug is a prohibited substance, thus non-medical usage is illegal. Only a few countries, including Spain and Turkey, still sell it medically.
History
Metenolone enanthate was approved for medicinal use in the US in 1962 as Nibal Depot. It was quickly withdrawn in the US and reintroduced in Europe in the 1960s and 1970s as Primobolan Depot.
Methenolone enanthate is the USAN, while methenolone is the BAN of metenolone. Conversely, metenolone is its INN.
Metenolone enanthate is also known as Nibal Injection and Primobolan Depot.
Primobolan Depot is an injectable methenolone. The enanthate ester in Primobolan orals (methenolone acetate) slows the steroid’s release from an injection site. Methenolone enanthate works similarly to testosterone enanthate, with blood hormone levels staying high for around two weeks. Methenolone is an anabolic steroid with minimal androgenic characteristics. Its anabolic impact is somewhat less than Deca-Durabolin (nandrolone decanoate). Enanthate is most frequently utilized during cutting cycles, when lean mass growth is the goal, not raw mass gain.
Dosages
For physique or performance enhancement, male athletes often take 200-400 mg per week for six to twelve weeks. Taking 600 mg or more per week is fairly uncommon, but this may emphasize methenolone’s androgenic side and aggravate its unfavorable effects on serum lipids. Female athletes react favorably to 50-100 mg each week. Oral versions are preferred over injectable ones because they enable better control over blood hormone levels. Even though this is a gentler anabolic steroid, virilizing adverse effects are possible.
Effects
Methenolone is not aromatized and is not estrogenic. This steroid should not cause estrogen-related adverse effects. Sensitive people should not be concerned about gynecomastia or water retention with this medication.
Although classed as an anabolic steroid, androgenic side effects are possible. Severe acne and body/face hair growth may occur. These steroids may exacerbate male pattern hair loss. Women are cautioned about AAS’s virilizing effects. They may include a deepening of the voice, clitoral enlargement, and menstrual abnormalities. Methenolone is still a weak steroid, and larger dosages usually cause significant androgenic adverse effects. Women often use this preparation since it is a pleasant and effective anabolic.
Methenolone is not a hepatotoxic steroid, thus liver damage is rare. When administered at therapeutic doses, the medication had no effect on indicators of hepatic stress.
Anabolic-androgenic drugs may raise blood cholesterol levels, increasing the risk of arteriosclerosis. Atherosclerosis, endothelial dysfunction, and enlargement of the left ventricle are all risk factors for cardiovascular disease and myocardial infarction. People with excessive cholesterol or a family history of heart disease should take AAS with caution. To assist decrease circulatory strain, keep up an active cardiovascular exercise routine and limit saturated fats, cholesterol, and simple carbs consumption when taking active AAS. Due to its non-aromatizable nature, methenolone should have a greater negative influence on hepatic cholesterol control than testosterone or nandrolone, but a lesser impact than c-17 alkylated steroids.
All AAS are anticipated to inhibit endogenous testosterone synthesis when taken in adequate levels to stimulate muscle growth. Due to its non-aromatizable nature, methenolone should provide less testosterone suppression than nandrolone or testosterone at a dose of 100-200 mg weekly. Moderate usage may result in faster recovery.
